THE COST-EFFECTIVENESS OF HEPATITIS C TREATMENTS IN TREATMENT NAIVE GENOTYPE 1 PATIENTS

被引：0
|
作者：
McGinnis, J. J. [1 ]
Hay, J. W. [1 ]
机构：
[1] Univ So Calif, Los Angeles, CA USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.1598
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN55
引用
收藏
页码：A274 / A274
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF PHARMACOTHERAPIES FOR TREATMENT NAIVE HEPATITIS C GENOTYPE 1 PATIENTS: A PAYER'S PERSPECTIVE
    Jalundhwala, Y. J.
    Manzoor, B. S.
    Patel, H.
    Cheng, W. H.
    Patel, P.
    Touchette, D. R.
    VALUE IN HEALTH, 2014, 17 (03) : A273 - A273
  • [2] Management of treatment-naive chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options
    Cortesi, P. A.
    Ciaccio, A.
    Rota, M.
    Lim, J. K.
    De Salvia, S.
    Okolicsanyi, S.
    Vinci, M.
    Belli, L. S.
    Mantovani, L. G.
    Strazzabosco, M.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 (02) : 175 - 183
  • [3] COST-EFFECTIVENESS OF HCV TREATMENT IN GENOTYPE 1 NAIVE PATIENTS IN 2012
    de Ledinghen, V.
    Orsini, M.
    Foucher, J.
    Vergniol, J.
    Chermak, F.
    Messaoudi, N.
    Daures, J. -P.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S384 - S385
  • [4] COST-EFFECTIVENESS OF TRIPLE THERAPY WITH TELAPREVIR FOR THE TREATMENT OF TREATMENT-NAIVE GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS IN GERMANY
    Stahmeyer, J. T.
    Schauer, S.
    Wirth, D.
    Fleischmann, J.
    Lee, S.
    Gavart, S.
    Bianic, F.
    Cure, S.
    Krauth, C.
    VALUE IN HEALTH, 2012, 15 (07) : A396 - A396
  • [5] COST-EFFECTIVENESS ANALYSIS OF A PERSONALIZED THERAPY FOR GENOTYPE 1, NAIVE, CHRONIC HEPATITIS C PATIENTS IN ITALY
    Iannazzo, S.
    Colombatto, P.
    Bonino, F.
    Brunetto, M. R.
    VALUE IN HEALTH, 2014, 17 (07) : A366 - A366
  • [6] A cost-effectiveness model to personalize antiviral therapy in naive patients with genotype 1 chronic hepatitis C
    Iannazzo, Sergio
    Colombatto, Piero
    Ricco, Gabriele
    Oliveri, Filippo
    Bonino, Ferruccio
    Brunetto, Maurizia R.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (03) : 249 - 254
  • [7] Cost-Effectiveness of Telaprevir in Patients with Genotype 1 Hepatitis C in Australia
    Warren, Emma
    Wright, Alison
    Jones, Brandon
    VALUE IN HEALTH, 2014, 17 (08) : 792 - 800
  • [8] COST-EFFECTIVENESS OF BOCEPREVIR IN THE TREATMENT OF CHRONIC HEPATITIS C GENOTYPE 1 IN SWEDEN
    Chhatwal, J.
    Lundberg, J.
    Ferrante, S.
    El Khourhy, A. C.
    Oksanen, A.
    Elbasha, E. H.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S386 - S387
  • [9] Cost-effectiveness of daclatasvir plus asunaprevir for chronic hepatitis C genotype 1b treatment-naive patients in China
    Lu, Yun
    Jin, Xiuze
    Duan, Cheng-a-xin
    Chang, Feng
    PLOS ONE, 2018, 13 (04):
  • [10] Cost-effectiveness analysis of simeprevir in combination with peginterferon and ribavirin for treatment-naive chronic hepatitis C genotype 1 patients in Japan
    Kuwabara, Hiroyo
    Westerhout, Kirsten
    Treur, Maarten
    Cerri, Karin
    Mahlich, Joerg
    Yatsuhashi, Hiroshi
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (07) : 502 - 511
12345